US Boosts Funding To Breed More Test Monkeys In Wake Of Covid glamsham.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from glamsham.com Daily Mail and Mail on Sunday newspapers.
Willamette Week
The need for strong, independent local journalism
is more urgent than ever. Please support the city we
love by joining Friends of Willamette Week.
WW Podblast: Research Monkeys Are Not Pets It’s a journey. This week,
WW released the highly anticipated Pets Issue. After several weeks of voting by our readers in our Pet Pageant, we determined the most prize-worthy animals in the city. And boy, they did not disappoint. As a podcast host, it is my duty to take the wonderful reporting that the
WW team does each week and figure out an angle that interests me—and hopefully you—the most. This week, I wanted to know two things about Oregon's animals. First, I wanted to know how to get the perfect pet picture. So, I hopped on a call with
The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine and drug research.
The NIH contract, awarded at $1.7 million for the first year, has the potential to reach up to $6.5 million over a four-year funding period.
Tulane will play a leading role in coordinating the evaluation of promising COVID-19 vaccines and therapeutics for COVTEN (Coronavirus Vaccine and Therapeutic Evaluation Network). The partnership will standardize research protocols and methods of data collection, share preliminary data and best practices across centers, and minimize the use of nonhuman primates by having single control groups across multiple studies. The centers, which normally conduct research independently, aim to harmonize their studies to provide more useful comparative data.
Tulane University to lead national research partnership to speed up COVID-19 vaccine discoveries A COVID-19 researcher in the biosafety level 3 laboratory at the Tulane National Primate Research Center. (Source: Tulane University) By Nicole Mumphrey | February 3, 2021 at 1:55 PM CST - Updated February 3 at 1:56 PM
NEW ORLEANS (WVUE) -The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine and drug research.
The NIH contract, awarded at $1.7 million for the first year, has the potential to reach up to $6.5 million over a four-year funding period.